Hansa Biopharma to Present at the Cowen 39th Annual Health Care Conference

March 06, 2019   |   March 2019 Bond Updates
LUND, Sweden, March 6, 2019 /PRNewswire/ -- Hansa Biopharma AB (NASDAQ Stockholm: HNSA), the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, announced today that Søren Tulstrup, President and CEO of Hansa Biopharma, will present at the Cowen 39th Annual Health ...

View more at: https://www.prnewswire.com:443/news-releases/hansa-biopharma-to-present-at-the-cowen-39th-annual-health-care-conference-300807520.html
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/